madman
Super Moderator
* Shalin stands firm in his belief that the descheduling of testosterone could lead to better public health outcomes.
*Explore the intricate world of testosterone replacement therapy side effects, particularly how different treatments impact hematocrit levels. We tackle the significant health risks linked to high-dose testosterone injections, such as erythrocytosis and polycythemia, and how Kyzatrex may offer a safer alternative. Delve into the potential benefits like maintaining endogenous testosterone levels, which could minimize risks of testicular atrophy and infertility.
Discover the future of testosterone replacement therapy as we welcome Shalin Shah, the visionary CEO of Marius Pharmaceuticals, who has made the bold leap from an investment background to the forefront of medical innovation. Shalin shares his journey and unveils Kyzatrex, the FDA-approved oral testosterone that promises to change the game by sidestepping the liver toxicity risks associated with earlier oral options. With Kyzatrex’s novel lymphatic absorption method, we showcase why this advance is the answer to the pressing demand for safer and more convenient testosterone treatments for both men and women.
Full disclosure
I use Kyzatrex with my patients who need testosterone at our Gatlan telemedicine practice. Explore the intricate world of testosterone replacement therapy side effects, particularly how different treatments impact hematocrit levels. We tackle the significant health risks linked to high-dose testosterone injections, such as erythrocytosis and polycythemia, and how Kyzatrex may offer a safer alternative. Delve into the potential benefits like maintaining endogenous testosterone levels, which could minimize risks of testicular atrophy and infertility. This episode is a must-listen for those wanting to understand the delicate balance involved in hormone therapy and the critical importance of patient education to avoid unintended health consequences. Lastly, immerse yourself in the transformative goals of the Testosterone Project, a nonprofit initiative championing routine testosterone testing for individuals over 40 and spotlighting testosterone's vital role in women's health. Shalin stands firm in his belief that the descheduling of testosterone could lead to better public health outcomes. This episode is packed with resources and insights into the evolving world of testosterone therapy, urging listeners to rethink conventional approaches and embrace innovative treatments. Join us in this critical conversation that promises to reshape how testosterone is perceived and utilized in healthcare
*Explore the intricate world of testosterone replacement therapy side effects, particularly how different treatments impact hematocrit levels. We tackle the significant health risks linked to high-dose testosterone injections, such as erythrocytosis and polycythemia, and how Kyzatrex may offer a safer alternative. Delve into the potential benefits like maintaining endogenous testosterone levels, which could minimize risks of testicular atrophy and infertility.
Discover the future of testosterone replacement therapy as we welcome Shalin Shah, the visionary CEO of Marius Pharmaceuticals, who has made the bold leap from an investment background to the forefront of medical innovation. Shalin shares his journey and unveils Kyzatrex, the FDA-approved oral testosterone that promises to change the game by sidestepping the liver toxicity risks associated with earlier oral options. With Kyzatrex’s novel lymphatic absorption method, we showcase why this advance is the answer to the pressing demand for safer and more convenient testosterone treatments for both men and women.
Full disclosure
I use Kyzatrex with my patients who need testosterone at our Gatlan telemedicine practice. Explore the intricate world of testosterone replacement therapy side effects, particularly how different treatments impact hematocrit levels. We tackle the significant health risks linked to high-dose testosterone injections, such as erythrocytosis and polycythemia, and how Kyzatrex may offer a safer alternative. Delve into the potential benefits like maintaining endogenous testosterone levels, which could minimize risks of testicular atrophy and infertility. This episode is a must-listen for those wanting to understand the delicate balance involved in hormone therapy and the critical importance of patient education to avoid unintended health consequences. Lastly, immerse yourself in the transformative goals of the Testosterone Project, a nonprofit initiative championing routine testosterone testing for individuals over 40 and spotlighting testosterone's vital role in women's health. Shalin stands firm in his belief that the descheduling of testosterone could lead to better public health outcomes. This episode is packed with resources and insights into the evolving world of testosterone therapy, urging listeners to rethink conventional approaches and embrace innovative treatments. Join us in this critical conversation that promises to reshape how testosterone is perceived and utilized in healthcare
